While it is known that febrile neutropenia is the most common reason for pediatric patients with cancer visiting the emergency department (ED), little had been known about the most common reasons for adult patients with cancer ending up in the ED.
When one of the 15.5 million people with cancer experiences a cancer-related complication, he or she is usually treated in the emergency department (ED). A recent study in JAMA Oncology examined the trends of adult cancer-related ED utilization to understand the factors that relate to inpatient admission.
The authors pointed out that the most common primary reason for 294,289 cancer-related visits to the ED from 2006 to 2010, in the pediatric population, was febrile neutropenia.
In a previous interview with The American Journal of Managed Care®, Daniel J. DeAngelo, MD, JD, of Harvard Medical School and the Dana-Farber Cancer Institute, who was not involved in the study, explained that patients with febrile neutropenia are often admitted to the hospital and started on antibiotics.
“Patients with neutropenia are at a risk of infection, sepsis, bacteremia, and the cost is hospitalization, broad-spectrum antibiotics, often anti-fungal therapy,” he explained. “And many patients become profoundly sick with sepsis or sepsis-like syndrome, requiring an intensive care stay.”
However, there is a gap in knowledge and in the evidence of how to care for patients with cancer in the ED. The study in JAMA Oncology sought to understand the overall utilization of the ED by patients with cancer, the clinical presentation of patients with cancer who end up in the ED, and factors associated with inpatient admission.
The authors found that patients with breast cancer had the highest frequency of ED visits, followed by prostate and other male genital cancers, lung cancer, and then patients with multiple cancers. From January 2006 and December 2012, 4.2% of ED visits by adult members of the population were related to cancer. The mean number of adult cancer-related visits per year for the 7 years studied was 4.2 million.
While the most common reason for pediatric patients with cancer visiting the ED was febrile neutropenia, the researchers found the most common reasons for adults with cancer to visit the ED was pneumonia, nonspecific chest pain, urinary tract infection, septicemia, and chronic obstructive pulmonary disease. Septicemia was the most common condition that resulted in inpatient admission. Overall, 59.7% of cancer-related ED visits resulted in an inpatient admission.
“Cancer care delivery research should focus on the significantly higher inpatient admission rate of cancer-related ED visits (59.7%) compared with noncancer ED visits,” the authors concluded. “Further study is needed to better describe cancer-related ED visits and to identify subpopulations in which ED physicians and oncologists can work together to improve patient care.”
The Long-term Social Value of Granulocyte Colony-Stimulating Factors
October 4th 2019Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.
Read More
Patients with hematologic malignancy who are undergoing chemotherapy or a conditioning regimen for hematopoietic stem cell transplant (HSCT) are at high risk of infection because of the severity and duration of neutropenia. Fever with neutropenia is a common presentation that suggests an infection leading to empiric antibacterial therapy. To prevent infection and thus the neutropenic fever, antibacterial prophylaxis, especially with fluoroquinolones, emerged as a common practice based on results of 2 randomized controlled trials published in 2005 that showed reduced incidence of fever and bacteremia despite lack of a mortality benefit.
Read More
Neutropenia Etiology Influences Resulting Hematologic Consequences
March 2nd 2019Hematological consequences of severe chronic neutropenia vary based on the underlying etiology of the condition, according to a study abstract presented at the 60th American Society of Hematology Annual Meeting & Exposition.
Read More
Home Monitoring Device for Blood Cell, Neutrophil Counts Shows Positive Initial Results
February 22nd 2019Initial results of a study have found that white blood cell counts and absolute neutrophil counts, which are well-established predictors of risk of infections or febrile neutropenia, can be accurately measured with a finger stick drop of blood and point-of-care hematology results.
Read More
The Long-term Social Value of Granulocyte Colony-Stimulating Factors
October 4th 2019Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.
Read More
Patients with hematologic malignancy who are undergoing chemotherapy or a conditioning regimen for hematopoietic stem cell transplant (HSCT) are at high risk of infection because of the severity and duration of neutropenia. Fever with neutropenia is a common presentation that suggests an infection leading to empiric antibacterial therapy. To prevent infection and thus the neutropenic fever, antibacterial prophylaxis, especially with fluoroquinolones, emerged as a common practice based on results of 2 randomized controlled trials published in 2005 that showed reduced incidence of fever and bacteremia despite lack of a mortality benefit.
Read More
Neutropenia Etiology Influences Resulting Hematologic Consequences
March 2nd 2019Hematological consequences of severe chronic neutropenia vary based on the underlying etiology of the condition, according to a study abstract presented at the 60th American Society of Hematology Annual Meeting & Exposition.
Read More
Home Monitoring Device for Blood Cell, Neutrophil Counts Shows Positive Initial Results
February 22nd 2019Initial results of a study have found that white blood cell counts and absolute neutrophil counts, which are well-established predictors of risk of infections or febrile neutropenia, can be accurately measured with a finger stick drop of blood and point-of-care hematology results.
Read More
2 Commerce Drive
Cranbury, NJ 08512